Fidelity Management & Research Company — Funding Activity & Portfolio Companies

Activity in this selectionOct 17, 2026 · Jul 20, 2026

Fidelity Management & Research Company is an investment adviser within Fidelity Investments, managing portfolios for investment funds and other clients, including exposure to private companies.

Fidelity’s research-led technology investing examines both public and private businesses. Its AI framework covers the computing components and infrastructure needed to run models as well as companies applying the technology, connecting private-company analysis with the wider listed market.

FMR manages capital through investment products and client mandates. A financing attributed to the manager can therefore involve fund-managed capital, rather than a standalone accelerator or a standard programme with a fixed investment offer for founders.

Sources

Rounds participated in: 6
Confirmed lead rounds: 1
New companies: 5
Funding in participating rounds: $540M

By stage

Series C+4

Growth1

Series B1

By primary sector

AI2

Biotech2

Hardware2

By country

United States6

Rounds

6 in this selection

Oct 13

Soufflé Therapeutics

Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.

$135MSeries B

Participant

Sep 28

SiMa.ai

SiMa.ai builds a full-stack physical AI platform that combines purpose-built silicon and software to help developers deploy machine learning on real-world devices.

$150MSeries C

Lead

Sep 17

Crusoe

AI infrastructure combining GPU cloud services, managed AI tools, large-scale data centers and modular AI factories for model developers and enterprises.

>$3.9BSeries F

Participant

Sep 3

Lyte

Lyte develops perception systems for robots and autonomous machines used in inspection, logistics and manufacturing.

$165MSeries C

Participant

Aug 10

Epicrispr Biotechnologies

Develops programmable epigenetic medicines to treat genetic diseases like FSHD

$90MSeries C

Role not disclosed